DeepMed Research

Chinese Academy of Medical Sciences Peking Union Medical College Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Prospective Study of Tocilizumab in the Treatment of Idiopathic Retroperitoneal Fibrosis

Phase 4

Conditions: Idiopathic Retroperitoneal Fibrosis

Interventions: Drug: Glucocorticoids
Drug: Tocilizumab

First Posted Date: 2021-02-21

Last Posted Date: 2021-03-22

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 40

Registration Number: NCT04762784

Locations: 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China

A Prospective Study of Cyclophosphamide Treatment for Idiopathic Retroperitoneal Fibrosis

Phase 4

Conditions: Idiopathic Retroperitoneal Fibrosis

Interventions: Drug: Cyclophosphamide and glucocorticoids
Drug: Glucocorticoids

First Posted Date: 2021-02-21

Last Posted Date: 2021-03-19

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 40

Registration Number: NCT04762810

Locations: 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China

Management Strategy of Polypoid Lesions of the Gallbladder

Completed

Conditions: Polyp Gallbladder

Interventions: Other: Non

First Posted Date: 2021-02-21

Last Posted Date: 2021-02-21

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 672

Registration Number: NCT04762797

Locations: 🇨🇳
Peking Union Medical College Hospital, Beijing, China

Effect and Safety of Smart Bra (PUMCH)

Not Applicable

Completed

Conditions: Effects of the Elements

Interventions: Device: smart bra

First Posted Date: 2021-02-18

Last Posted Date: 2021-10-21

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 2141

Registration Number: NCT04761211

Locations: 🇨🇳
Breast Surgery Department of PUMCH, Beijing, Beijing, China

3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver Metastases

Conditions: Colorectal Cancer
Colorectal Cancer Liver Metastasis

Interventions: Procedure: surgical resection
Other: adjuvant chemotherapy
Other: neoadjuvant therapy

First Posted Date: 2021-02-16

Last Posted Date: 2022-07-19

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 120

Registration Number: NCT04755907

Locations: 🇨🇳
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
🇨🇳
China-Japan Friendship Hospital, Beijing, Beijing, China
🇨🇳
Beijing Cancer Hospital, Beijing, Beijing, China

and more 1 locations

Different Immunosuppressive Treatment in iMN

Phase 3

Recruiting

Conditions: Idiopathic Membranous Nephropathy

Interventions: Drug: Prednisone
Drug: Rituximab
Drug: Cyclophosphamide

First Posted Date: 2021-02-09

Last Posted Date: 2022-04-20

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 200

Registration Number: NCT04745728

Locations: 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China

Zanuburutinib in Relapsed and Refractory iMCD: a Prospective, Single-center, Single-arm Trial

Phase 2

Recruiting

Conditions: Idiopathic Multicentric Castleman's Disease

Interventions: Drug: Zanubrutinib

First Posted Date: 2021-02-08

Last Posted Date: 2021-02-09

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 30

Registration Number: NCT04743687

Locations: 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China

Rituximab Combined With Cyclosporine Versus Rituximab Alone in the Treatment of iMN

Phase 3

Recruiting

Conditions: Idiopathic Membranous Nephropathy

Interventions: Drug: Rituximab
Drug: cyclosporine

First Posted Date: 2021-02-08

Last Posted Date: 2021-05-18

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 126

Registration Number: NCT04743739

Locations: 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
🇨🇳
Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
🇨🇳
Beijing Tongren Hospital， Capital Medical University, Beijing, Beijing, China

and more 4 locations

A Study of Alendronate Sodium Vitamin D3 Tablets on Knee Osteoarthritis

Phase 4

Conditions: Knee Osteoarthritis

Interventions: Drug: alendronate sodium vitamin D3 tablets
Drug: Placebo

First Posted Date: 2021-02-04

Last Posted Date: 2022-04-22

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 60

Registration Number: NCT04739592

Locations: 🇨🇳
The Third Affiliated Hospital of Southern Medical University, Guangzhou, China
🇨🇳
Peking Union Medical College Hospital, Beijing, China
🇨🇳
Zhongshan Hospital, Shanghai, China

The Study of EIT-guided Ventilation Strategy on ARDS Patients

Not Applicable

Conditions: Pulmonary Perfusion
ARDS

Interventions: Procedure: EIT-guided PEEP setting
Procedure: ARDS-net PEEP setting

First Posted Date: 2021-02-02

Last Posted Date: 2021-02-02

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 100

Registration Number: NCT04734340

Locations: 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy